Press release: Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory ...
Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis alfapump® is the first US approved active implantable medical device (Class III) for the treatment of recurrent or refractory …